GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd. share price is ₹2,700.00 as of July 26, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

The 52-week high and low of GlaxoSmithKline Pharmaceuticals Ltd. is ₹2,825.00 and ₹1,386.15 respectively as of July 26, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

The trailing twelve month (TTM) PB ratio of GlaxoSmithKline Pharmaceuticals Ltd. is 25.80 as of July 27, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

The Upper Circuit of GlaxoSmithKline Pharmaceuticals Ltd. is ₹3,249. The Lower Circuit of GlaxoSmithKline Pharmaceuticals Ltd. is ₹2,166.

GlaxoSmithKline Pharmaceuticals Ltd. reported an ROE of 33.53% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for GlaxoSmithKline Pharmaceuticals Ltd., Promoter held 75%, the FII held 4%, DII held 7.5% and the public held 13.5% of the total shares.

You can easily buy shares of GlaxoSmithKline Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of GlaxoSmithKline Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.